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Acontinuing
need for

scholarship
support
Turn this card for the inspiring story
of agenerous legacy that still helps
students at the School of Medicine.

Support for today's students
means a future of beneficial care
and scientific breakthroughs.
See page 36
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Jackson Johnson

His generosity lives on
"Under the will of the late Jackson Johnson, the sum
of $250,000 was donated to the School of Medicine,
the income of which is to be used to aid worthy and
desirable students in acquiring and completing their
medical education,"
With th is brief item in the 1930 Washington
University School of Medicine Bulletin, so began the
endowed Jackson Johnson Scholarship Fund,
Jackson Johnson was president of International
Shoe Company, the largest shoe manufacturer in th e
country early in the 20th century. He was elected to
the Washington University Board ofTrustees in 1919
and served until his death in 1929. He endowed the
Jackson Johnson Scholarship Fund in memory of
his son, Jackson Johnson Jr., wholost his life in "the
Service of the United States during the Great War:'
Coming during the Great Depression, these
resources were critical in making it possiblefor
aspiring young Students to pursue their medical
educations. And for over 70 years, this scholarship
fund has continued to do just that. Sin ce itsincep
tion, more than 700 young men and women have
received about $1 million in finan cial assi stan ce ,
To maintain its reputation for excellence,
Washington University School of Medicine must
continue to attract the most promi sing and best
qualified students, Many of these exceptional
students will require financial assistance, and the
need for scholarship support is growing faster than
available resources can sustain.

To learn more about how you can
make an impact, please contact the
Office of Medical Alumni and Development
at (314) 935-9691.

;SWashington
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St. Louis Children's Hospital

PHOTO ESSAY

The colorful, inviting atmosphere of St. Louis
Children's Hospital helps put patients and
their families at ease.

Scratching the Surface

1

Study of a specific pain-senSing gene shows
that pain and itching - long thought to be
connected - are separate nerve functions.

Critical Differences Count

1

A faster, less-expensive method of identifying
rare genetic variants in human DNA speeds the
diagnosis and treatment of pediatric cancers.

Safer Passage
A new twist on a surgical instrument allows
physicians to remove pituitary and other brain
tumors without opening a patient's skull.

COVER Alan L. Schwartz, PhD, MD, the
Harriet B. Spoehrer Professor of Pediatrics
and head of the Department of Pediatrics at
Washington University School of Medicine, is
also pediatrician-in-chief at SI. Louis Children's
Hospital. Schwartz stands in front of a colorful
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special place for care, please turn to page 8.
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Performance of visuospatial tasIIs such
as "trailmarlcing" (connecting the dots)

25

may allow earlier detection Of Alzheimer's
as earlier treatment that

23
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Connecting dots

mental skills: episodic memory, visuospatial
skills and working memory -

the ability

to manipulate facts from memory, such as
repeating a list of numbers backwards.

Simple skills tests may help with earlier detection of Alzheimer's

Declines in episodic and working memory
were discernible a year before diagnosis with

new study of mental decline in
the years prior to diagnosis of
Alzheimer's disease suggests

The study results were published in the
October 2009 issue of Archives of Neurology.
Galvin and his coauthors analyzed long

that changing the focus of testing may

term data from volunteers with the Memory

allow earlier detection of the disease.

and Aging Project at Washington University's

Current cognitive testing focuses on

Alzheimer's Disease Research Center (ADRC).

Alzheimer's. Losses in the composite assess
ment of cognitive abilities were detectable
two years prior to diagnosis, and visuospatial
skills began to decline three years earlier.
The new perspective may allow doctors
to detect signs of Alzheimer's earlier, but

episodic memory, the ability to remember

For three decades, ADRC researchers have

more information will be needed to make a

things like word lists or information from

conducted extensive testing of volunteers

firm diagnosis. To make that possible, ADRC

a reading . But scientists at the School of

to uncover factors associated with the nor

researchers are correlating information

Medicine have found that another class of

mal, healthy retention of mental function in

from the new study with biomarkers, the

mental abilities, visuospatial skills, begins

seniors. The new study analyzes data on

physical changes associated with preclinical

to deteriorate up to three years prior to

444 volunteers ages 60 to 101 that were

Alzheimer's disease. These include scanning

diagnosis. These skills are tested with tasks

gathered between 1979 and 2006.

the brain for amyloid plaques, a primary

such as connecting the dots or using a
guide to build a structure with blocks.
"We may need to rethink what we look

Scientists categorized the new study's

characteristic of Alzheimer's that can begin

results into a global measure of cognitive

building in patients 10 years or more before

abilities as well as three specific types of

clinical symptoms become apparent, or ana

for as the earliest signs of mental change

lyzing protein levels in the cerebrospinal fluid.

associated with Alzheimer's disease;' says

"The new findings raise the question

senior author James E. Galvin, MD, MS, a

of what changes are occurring in the brain

Washington University neurologist who is

during the one- to three-year period prior

also on staff at Barnes-Jewish Hospital. "If we

to diagnosis;' Galvin says. "Patients have had

can better recognize the first signs of disease,

plaques in their brain for years, and suddenly

we can start treating patients earlier, and

their cognitive abilities begin to deteriorate.

hopefully with new treatments we can slow

Is a threshold being crossed where brain cell

or perhaps even stop their progress into

Psychometrician Molly Aeschlemann, left, conducts a

death begins to occur or really starts to pick

dementia:'

trailmarking test with study volunteer Jan Bunch.

up speed?"

2 Washington University School of Medicine
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Federal recovery act aboon for
research across multiple fields
WUSTL among top 10 for NIH funds
Washington University in St. Louis has been awarded nearly
$80 million in funding from the 2009 American Recovery
and Reinvestment Act (ARRA) to support research across a
broad range of projects, including cancer, Alzheimer's disease,
renewable energy, diabetes and climate change.
As of September 30, the end of the federal fiscal yea r,
175 university faculty members had received 207 awards.
Some $73 million came from the National In st itutes of
Health (NIH); other awards came from the National Science
Fou ndation and the Department of Energy.
The largest chunk - $10 million - went to the Genome
Center for a project to generate comprehensive genetic maps
of mutations that underlie 20 types of cancer. Over time, the
project is expected to lead to new ways to diagnose , treat or
even prevent cancer. Other awards to School of Medicine
researchers will support:
o Testing an MRI-based
heart-imaging technique that
has the potential to deter
mine whether heart mu scle is
alive or dead more accurately
than currently available tests.
The technique offers unprec
edented precision and may
help to improve the effective
Advanced heart imaging detects
. .
ness of cardiac surgery.
functional anomalies (red and yellow)
Investigating ways to
0

diagnose Alzheimer's di sease before the onset of dementia by
combining inform ation from brain sca ns that image amyloid
plaques - a key feature of Alzheimer's - with an analysis
of key proteins in spinal fluid. Earlier diagnosis could allow
patients to receive new treatments before the disea se causes
irreversible brain changes that lead to memory loss.
o Establishing a program that helps guide women in poor,
minority communities in north St. Louis County through
breast cancer screening and follow-up treatment, if needed.
TIle awards have a significant economic impact in the
St. Loui s region. A recent survey by Families USA Foundation
showed that every dollar of NIH funding to Missouri in 2007
generated $2.09 of economic activity in the community that
received the award.
"By this estimate, recent stimulus funding to Washington
University will generate well over $200 million in goods and
services in our region," says Evan D. Kharasch, MD, PhD, the
university's interim vice chancellor of research. "Moreover,
research conducted with s timulu s funds furthers our efforts
to improve the lives of all people."
outlook.wustl.edu

Solnica-Krezel new department head
Lilianna Solnica-Krezel, PhD, has been chosen to head the
Department of Developmental Biology. She succeeds interim
head David M. Ornitz, MD, PhD, who has returned to ful1
time research and teaching responsibilities after holding the
position since October 2004.
Solnica-Krezel comes to St. Louis from Vanderbilt
University, where she was the Universi ty Professor and
the Martha Rivers Ingram Professor of
Developmental Genetics. She also is a
professor of biological sciences, pediatrics,
cell biology and phYSiology, and develop
mental biology.
In 2007, the Department of Molecular
Biology and Pharmacology became the
Department of Developmental Biology,
reflecting a shift in research focus. During
the past 15 years, the department has
recruited researchers interested in embry
onic development, aging, regenerative biol- Lilianna Solnica·Krezel, PhD
ogy and phYSiology. Its focu s now encompasses an orga nism's
development throu gh life.
Solnica-Krezel studies molecular and genetic mechanisms
that control the early development of vertebrate an ima Is.
She has studied this process in zebra fish, using a combina
tion of genetic analysis with embryological and mol ec ular
methods. She has received multiple research grants from the
National Institutes of Health, March of Dimes Birth Defects
Foundation and Human Frontier Science Program.
Outlook 3
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Treatments improve outlook
for pancreatic cancer patients
Clinical trials examine drug reactions
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Institute of Medicine elects DeBaun
iVlichael R. DeBaun, MD, has been elected to the Institute of
Medicine of the National Academy of Sciences, one of the
highest honors that U.S . medical scientists can receive.
DeBaun, who holds the Ferring Family Chair in Pediatric
Cancer and Related Disorders and is a professor of pediatrics,
biostatistics and neurology, was recognized for his major
contributions to the advancement of the medical sciences,
health care and public health.
He has established an intern a tionally
renowned program for treatment, educa
tion and research into the complications
of sickle cell disease. Under his leadership,
a team of investigators received funding
for the first NIH-sponsored international
clinical trial in sickle cell disease. His
research also has focused on determining
the epidemiology, clinical significance
and genetic basis for asthma and pain in
Michael R. DeBaun, MD
children with sickle cell disease.
DeBaun , who also is a pediatrician at St. Louis Children's
Hospital, has initiated many community-based activities to
improve the quality of life for individuals with sickle cell
disease. These include a camp for children with the disease;
the Charles Drew program, a cooperative effort with the
American Red Cross to increase the number of African
American blood donors; and Sickle Cell Sabbath, a faith
based educational program about sickle cell disease,
4 Washington University School of Medicine

A team of surgeons and oncologists at the Siteman Cancer
Center at Washington University School of Ivledicine and
Barnes- Jewish Hospital is aggressively tackling pancreatic
cancer - one of the dead liest forms of the disea se - and
conducting clinical trials of innovative treatment regimens,
"The perception of
video feature at:
many people is that once
mednews.wustl.edu
you receive a diagnosis of
pancreatic cancer there's not much that can be done,
but that's not true," says David C. Linehan, MD, associate
professor of surgery. "We're attacking this very difficult
disea se from multiple angles; it 's a team effort. One of our
areas of focus is ways to manipulate the immune system so
that it can fight the tumor."
Their latest clinical endeavor yielded promising results by
including the immune-system stimulator interferon along
with chemotherapy and radiation in patients who had their
pancreatic tumors surgically removed, In a study published
in the Annals afSurgery, the team reported that the three
year survival rate was 41 percent for patients on this regi
men. In comparison, typical three-year survival rates are
about 30 percent.
Linehan and colleagues are part of the largest regional
surgical referral center for disorders of the liver, gallbladder,
pancrea s and GI tract. Many of their patients have survived
five or more years after diagnosis, The tea m is continuing to
initiate new trials for pancreatic cancer and plans to start a
second trial of interferon-based therapy to attempt to reduce
adverse reactions by altering time and dosage,

Becker honored for leadership role
Bernard Becker, MD, who headed the
School of Medicine's Department of
Ophthalmology and Visual Sciences
from 1953 to 1988, is this year's
recipient of the American Academy of
Ophthalmology's highes t honor:
the 2009 Laureate Recognition Award.
Becker, lecturer a nd professor
emeritus, was recognized for his
pioneering efforts in research, clinical
care and education,
Bernard Becker, MD
Under his tenure, the department
became internationally recognized for exceptional research
and teaching, Many residents who trained with Becker now
serve as department heads or hold other prominent pOSitions
in academic ophthalmology throughout the world.
Winter 2009

OPHTHALMOLOGY AND VISUAL SCIENCES

Out ofthe darkness and into the light

E

ver wonder how your eyes adjust
during a blackout? When we go
from light to near total darkness,
cells in the retina must quickly adjust.
Vision scientists at the School of Medicine
have identified an intricate process that
allows the human eye to adapt to darkness.

The same process also allows the eye to
function in bright light.
The discovery could contribute to better
understanding of human diseases that affect
the retina, including age-related macular
degeneration. That's because the disease
and the pathway that researchers identified
involve the same cells called cone cells.
"Age-related macular degeneration may
be modulated, perhaps, through this path
way we've identified in the retina;' says prin
cipal investigator Vladimir J. Kefalov, PhD.
"Deficiencies in this pathway affect cone
cells, and so does macular degeneration, so
it's possible that if we could enhance activ
ity in this pathway, we could prevent or
reverse some of that damage to cone cells."
outlook.wustl.edu

The retina's main light-sensing cells
are called rods and cones. Previous animal
studies showed that cones rely on light
sensing molecules that bind together to
make up visual pigments. The pigments are
destroyed when they absorb light and must
be rebuilt, or recycled, for the cone cells to
continue sensing light. When this recycling
was prevented, the rods no longer worked,
but the cones continued to function . This

made it clear to the researchers that a
second pathway was involved.
To determine what made this possible,
Kefalov's team focused on Muller cells, a
particular cell type in the retina that sup
ports and interacts with rods and cones.
They destroyed the Muller cells in animal
models, then exposed the retina to bright
light, followed by darkness. "When we did
this, the retinal visual pathway could not
function because cones ran out of photo
pigment and could not adapt to dark:'
The results, published in the October 13,
2009 issue of Current Biology, suggest that
Muller cells are key to this pathway in mam
mals, including humans. When those cells
function properly, cones are able to func
tion in bright light and adapt to darkness,
independently of the pigment epithelium.
This discovery means it may one day
be possible to manipulate this pathway in
the retina to improve vision when the other
pathway, involving pigment epithelium,
has been interrupted by injury or disease.
Outlook 5
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Multinational effort to study
Hispanic health and disease
Mortality, economic impact are focus

Milbrandt named genetics head
Jeffrey D. Milbrandt, MD, PhD, has been named head of
the Department of Genetics and the James S. McDonnell
Professor. He succeeds interim head Susan K. Dutcher, PhD,
who had held the position since June 2006.
Milbrandt, who joined the School of Medicine faculty in
1983, brings a strength in basic and tran slational science to
the position and an appreciation of the expanding role of
genetics in the diagnosis, prognosis and treatment of disease.
As head of genetics, he hopes to bol ster faculty collaborations
with researchers in clinical and preclinical
departments and encourage investigations
that utilize genetic analysis to understand
basic mechanisms of disease.
The department is widely recognized
for its study of fund am ental genetic
mechanisms that underlie biological pro 
cesses. The department also includes the
world-renowned Genome Center, whose
scientists played a leading role in the
Human Genome Project. More recently,
Jeffrey D. Milbrandt, MD, PhD
these scientists have pioneered the decod
ing of cancer patients' genomes to identify genetic changes
at the root of the disease. Computational biologists in the
depar tment are highly regarded for their study of complex
genetic networks and the statistica l analysis of genetic data.
Milbrandt's own research has focused on neuronal
signaling cascades stimulated by neurotrophic factors and
on understanding how glial cells contribute to axonal
regeneration after nerve injury.
6 Washington University School of Medicine

The Prevention Research Center (PRC) in St. Louis is launch
ing a multinational research project focused on preventing
the leading causes of death in Hispanics in the United States
and Latin America. The project is funded by the Centers
for Disease Control and Preve ntion's National Center for
Chronic Disease Prevention and Health Promotion .
The PRC in St. Louis, a collaboration between Washington
University and Sa int Loui s University, will conduct a four
year, $2.8 million effort to apply and adapt evidence-based
strategies for preventing heart disease, cancer, diabetes and
obesity in the United States, Mexico and Brazil.
"By understanding strategies for physical activity promo
tion that work in Latin America, we will be better able to
address the needs and prefer
ences of Hispanic populations
in the United States," says Ross
C. Brown so n, Ph D, project
director and professor at the
university's School of Medicine
and the George Warren Brown
School of Social Work.
Chronic diseases are a grow
ing challenge for public health
in Latin America and globally. Physical education taught in public
In Brazil, chronic diseases such spaces improves community health.
as heart attack and stroke are leading causes of mortality,
generating premature deaths and economic burden.
In a previous phase of this project , PRC researc hers evalu
ated evidence from physical activity intervention s carried out
in community settings in Recife, Brazil. Physical education
instructors there taught free calisthenic and dance classes
in public spaces, led walking groups and provided nutrition
information. Scientists determined that the project greatly
increased physical activity among community members.
In the project's current phase, researchers will dis
seminate results from the previous study to communities,
in st itutions and public health professionals in Brazil and
across Latin America. They also may teach school adminis 
trators and public health and medical professionals the latest
approaches to physical activity as well as evaluate innovative
exerc ise programs in schools and parks in Brazil.
"We hope this new program will build on what we have
a lready learned," says Brownson, also a faculty scholar
of Washington University 's In sti tute for Public Health.
"Co upled with healthy eating, physical activity can help
prevent and control diabetes , hypertension and heart
disease, resulting in improved quality of life and health."
Winter 2009
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ALS model mirrors human disorder

A

ew mouse model of amyotrophic
lateral sclerosis (ALS) closely

Washington University scientists Nigel

J. Cairns, PhD, and Alison Goate, PhD,

In addition to helping researchers under
stand what causes some forms of ALS, the

resembles the paralyzing
disorder in humans, researchers at the

sequenced a point mutation in the TDP-43

new mouse model may provide an impor

gene of a St. Louis family with an inher

tant tool for screening new drugs. Scientists

School of Medicine reported in the

ited form of ALS, and Baloh's lab created a

already have another mouse model of ALS

November 3,2009 issue of Proceedings of

mouse line with the family's mutation.

with a mutation in SOD1, the first gene to

the National Academy ofSciences.
Like humans with ALS, the mice studied
develop progressive paralysis; lose muscle
mass and specific types of motor neurons,
which are nerve cells that control muscles;
and die of the disorder, which is currently
fatal in humans.
"As far as we know, this is the first
mouse model that recapitulates 'typical'
ALS to be produced in more than a decade,"
says senior author Robert H. Baloh, MD,
Ph D, assista nt professor of neu rology. "That
could make it very helpful for our efforts to
better understand and identify treatments
for this terrible disorder:'
The mice have a point mutation or
single letter of erroneous DNA code in
the gene for a protein called TDP-43.

outlook.wustl.edu

"TDP-43 is only the second gene to be
linked to an inherited form of ALS that

be linked to an inherited form of ALS with
typical symptoms. However, according to

appears clinically identical to sporadic ALS,

Baloh, it hasn't always been the best tool

and it's very promising that this similarity

for predicting whether treatments will work

The utility of this model
to mirror human ALS
should aid development
of better treatments.

in humans.
"If we use the two models together
to test potential treatments, that might
provide us with a much finer screen;' says
Baloh. "This could help relieve some frus

'

tration in the field, because there are a

r

number of new drugs ready to be tested
allows the symptoms of sporadic ALS to be

in humans, and we urgently need ways to

accurately modeled in mice;' Baloh says.

determine which should be tried first:'
The TDP-43 mice also have brain dam

While mice typically live more than two
years, mice with the TDP-43 mutation live

age similar to patients with frontotemporal

only five months. Like humans, the mice

dementia, a disorder sometimes associated

develop problems with walking, lose mus

with ALS. Baloh and colleagues will use the

cle mass and eventually become paralyzed.

mice to explore the potential connection .

Outlook 7
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While studying a
specific gene for
pain, researchers
happened upon an
explanation for itch
that could lead to
better chronic itch
management
BY JIM DRYDEN

As native St. Louisan and baseball philosopher Yogi Berra once said:
"You can observe a lot just by watching." Although he never heard
Berra's famous "Yogi-isms" while growing up in China, Zhou-Feng
Chen, PhD, has followed the former catcher's sage advice anyway.
Chen decided that if he wanted to learn whether an animal is itchy,
an easy way to find out would be to watch and see whether the animal
scratches. So for the last couple of years, Chen and others in his labora
tory have spent a good deal of time watching mice scratch.
It all began when Chen, an associate professor of anesthesiology,
psychiatry and developmental biology was trying to learn more about
pain sensation. His laboratory was looking for genes in the spinal
cord that might be related to the pain response. Itch also was involved
because historically, scientists had thought of the itch response as being
a slightly less intense version of pain and that both sensations were
transmitted through the same neural pathway.
That's what it said in the neurology textbooks, anyway. As it turns
out, those textbooks were wrong.

While searching for genes related
of the neurotoxin caused the mice
to pain, Chen's lab began studying a
to scratch 80 percent less and, in
some cases, eliminated scratching
gene called GRPR (gastrin-releasing
peptide receptor). Among the poten
altogether.
Further tests on the mice showed
tial pain-sensing genes they identified,
that other neurologiC functions, such
GRPR stood out because it was active on
as motor control, were not affected when
a relatively small number of nerve cells in
GRPR-expressing neurons were destroyed.
the spinal cord.
But, as with the mice without GRPR, the pain
To get an idea of what the gene was doing, they
response wasn't affected. "This finding has very important
studied mice without the GRPR gene to learn how they were
different from normal animals.
implications for therapy," says Chen, who also is an investi
gator at Washington University's Pain Center. "We've dem
"At first, we were a little bit disappointed," Chen says,
"because the mice without a GRPR gene seemed to react to
onstrated that GRPR functions on specific neurons that are
critical for itching, but not for pain."
painful stimuli in the same way normal mice did."
But then they injected the normal mice with a substance
The ability to separate pain sensation from itch suggests
that stimulates GRPR, and the mice started to scratch.
that it may be possible to treat itch with drugs that don't
"That's when we thought the gene might be
alter the pain response, and vice versa.
related to itch sensation," Chen says. "So we
That's
important because pain can be an
The ability to
began to look carefully at the itch response in
important protective cue that warns of
danger, says Alex S. Evers, MD, the Henry
mice with and without GRPR."
separate pain
E. Mallinckrodt Professor and head of
They studied itching by watching the
mice scratch, and the researchers found
sensation from itch the Department of Anesthesiology. "This
means that potentially we can design
that the normal mice scratched vigorously
when exposed to a variety of itch-producing
suggests that it may agents that selectively block out the
substances. The mice without GRPR, on
pruritic side effects of pain-killing drugs,
be possible to treat particularly opiates," says Evers. "This
the other hand, scratched less.
could be important in allowing better
But when either strain of mouse was
itch with drugs that analgesic therapy in a variety of situations
exposed to painful stimuli, such as an injec
tion, the mice without GRPR withdrew and
from cancer pain to labor pain."
don't alter the pain
Itching is a common side effect of
licked themselves just like the normal mice.
painkillers like morphine, and treatment
So, although they reacted very differently
response.
options for itchy patients have been lim
to itchy things, they both avoided pain and
ited. But Chen's team already has decou
reacted to painful stimuli in identical ways.
From that behavior, Chen was able to recognize that pain
pled itching induced by opiates from pain control in mice.
"If we inject a GRPR inhibitor and morphine into the
and itch were not two parts of the same response, but were
spinal cord in the mouse, the drug continues to have its
different responses altogether.
analgeSiC effect, but the mice don't scratch," Chen says.
This told the researchers that GRPR was helping to
"That proVides still more evidence that analgeSia and itching
regulate itch and, because the gene was functional only on
a small number of neurons, Chen's team zeroed in on those
can be separated."
particular cells to see whether they made up an itch-specific
Many human patients with chronic pain receive spinal
pathway in the spinal cord.
perfusions of opioid drugs to control their pain. Perhaps,
In the September 18,2009 issue of the journal Science,
Chen says, one day those patients may receive the opioid
Chen reported that such a pathway was likely. Unlike the
drug along with a second drug that inhibits GRPR so that
earlier experiments involving mice without GRPR, this time
they can enjoy the benefit of pain relief without the side
effect of itching.
Chen's team injected the spinal cords of normal mice with a
neurotoxin called bombesin-saporin. The neurotoxin binds
Chen is now working to characterize the itch-specific
to GRPR, and it killed the neurons that had a functional
neuronal pathway. He's also studying GRPR-expressing
neurons in the spinal cord, looking for other genes that may
GRPR gene.
be related to the itch response. Meanwhile, he continues to
Then they looked at the mouse behavior again. When the
keep an eye on his mice because, after all, you really can
mice injected with bombesin-saporin were exposed to things
that caused itching, they didn't scratch. An appropriate dose
observe a lot just by watching.
SEE GRAPHIC NEXT PAGE
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receptor-expressing -'
neurons (dark spots)
within the spine

major motivation behind the $3 billion project
to decode the human genome was that it would
enable scientists to sift through the sequence
of letters that make up DNA to find common
changes that predispose individuals to
common diseases, such as cancer, diabetes or Alzheimer's.
But this first step toward personalized genomic medicine
has turned out to be far more complex than expected.
Many genetic studies have compared common variations
in the DNA of healthy people and sick patients, finding dozens
of changes linked to diseases. But variations identified to date
account for only a small percentage - typically 1 percent to
3 percent - of overall genetic risk for any particular disease.
That disappointment has led a growing number of
scientists to suspect that rare genetic variants lie at the root
of many common diseases. But short of sequencing the com
plete genomes of many thousands of individuals - a highly
expensive and time-consuming task even with the latest
DNA sequencing technology - no reliable method exists to
identify rare variants or interpret their influence on disease.
"There's intense interest in rare variants right now," says
pediatric oncologist Todd E. Druley, MD, PhD. "We couldn't
wait until whole-genome sequencing became cost effective
before we started our search."
The urgency hits home every time Druley has to tell par
ents their child has cancer. "Of course, the first thing parents
want to know is whether their child will die. Then, invariably,
they ask: 'Why did this happen to my child?'"
Not knowing the answer was the driving force behind
Druley's efforts to find a way to search for rare variants.
Toward that end, he teamed with Robi D. Mitra, PhD,

Critical
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A highly efficient - and effective 
method for finding disease-related genes
takes a shortcut via complex math
BY CAROLINE ARBANAS
Photo above, from left: Todd E. Druley, MD, PhD,
Robi D. Mitra, PhD, and Fran(es(o Vallania
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collect large volumes of genetic data.
"We think children with cancer are likely
to have a unique collection of rare, inherited
DNA variations that predispose them to their
disease or to difficulties metabolizing the medications used to
treat cancer," Mitra says. "Rare variants likely contribute to
disease in adults, too, but until now, we haven 't even had a
way to investigate the link."
With funding from the Children's Discovery Institute, the
team developed a way to find and quantify all the inherited
rare genetic variants in a complete set of human genes. Their
method is fast and inexpensive - and incredibly accurate,
they reported in the April 2009 issue of Nature Methods.
The approach, which combines next-generation DNA
sequencing technology with a computer program the
research team developed, has attracted the attention of other
scientists. The team now is working with the Children's
Oncology Group, the global clinical trials cooperative, to
identify rare variants in pediatric cancer patients with an
aggressive form of leukemia .
Winter 2009

Qj,d,s (E) = 2- nj ,d,sD(Pj ,d,sIlQj,d,s)
Adapting Sanov's theorem resulted in a more efficient variation-finder.

Doing the math
T

he question was how
to tell an unusual gene

from a technical glitch.
Researchers sought to

In order to distinguish a
real SNP from sequencing
noise, the research team
developed a novel algorithm

determine variations that

based on an application of

altered a single letter in the

Sanov's theorem, which was

genetic code (A, C, G or T),

borrowed from the field of

called single nucleotide

information theory.

polymorph isms (SNPs). This

An added mathematical

problem becomes really

model of known error rates

challenging when looking

aided comparisons with the

at rare genomic variation

observed genetic variations.

because SNPs largely

The result: accurate and

overlap with background

more efficient detection of

errors generated d uri ng

rare SNPs down to 1 mutation

the sequencing process.

in 1,111 individuals.

SNPs (red) align with expected errors (blue) in this detail of a larger graph.

T

he bulk of the 3 billion pairs of chemical bases that
make up DNA - represented by the letters A, T, C
and G - are identical from one person to the next.
But the exact order of the letters varies, often at a single
location, in some 10 million common spots in the genome.
These variations are what make each individual unique.
Each person also has about 300,000 rare genetic alterations
buried within the genome. These variations mean nothing by
themselves ; it's only in the context of a large group that scien
tists can identify their links to a particular disease.
To find individual DNA samples to search for rare variants,
Druley and Mitra turned to F. Sessions Cole, MD, the Park J.
White MD Professor of Pediatrics and director of the Division
of Newborn Medicine, who provided his collection of thou
sands of blood samples collected from the heels of newborns.
The researchers pooled the DNA of 1,111 newborns and
targeted four genes. To ensure accurate results, they created
thousands of copies of the four genes and sequenced them
many times to identify the full spectrum of genetic variation.
TIle genes of interest included surfactant protein B, wbich
Cole discovered in 1993 and linked to respiratory distress
syndrome in infants. Cole had painstakingly sequenced the
gene in all 1,111 individuals with traditional sequencing
methods; Mitra and Druley used the gene as a control.
"We wondered whether we would find the same variants
at the same frequencies in our pooled sample that Dr. Cole
had already identified," Mitra says.
outlook. wustl.edu

They also looked for rare variants in two genes important
in cancer - p53 and APC - as well as in beta actin. None of
these three genes had been sequenced in the 1,111 individuals.
In all, the team sifted through a haystack of 4.5 billion
DNA bases. TIley found 64 variants in the four genes, nearly
two-thirds of which were identified in less than 1 percent
of the individuals, making them rare. These included four
variants that had not been previously identified . Three of
them occurred in the two cancer genes.
The computer algorithm, developed in collaboration
with graduate student Francesco Vallania, acc urately distin
guished between rare variants and sequencing errors most
of the ti me. "This is crucial because rare variants can easily
look like sequencing errors," Mitra says. "How do you tell
the difference? The algorithm we developed could do that."
The researchers accurately recapitulated all of Cole's data,
finding variants at the predicted frequencies in the surfactant
protein B gene. They also went back to verify the frequencies
of variants in the otber three genes. In all, they accurately
identified all the rare variants in the pooled sample. They
also identified sequencing errors as mistakes 99.S percent of
the time. Overall, the algorithm was 96 percent accurate.
With the new method, the sequencing that took Cole
2.5 years at a cost of $200,000 was completed in just four
months for $6,000.
"This provides proof of principle," Druley says. "We're
now testing the approach in children with aggressive leuke
mia and in healthy children to see whether we can find
rare variants linked to the disease."
Ideally, the team hopes to identify rare variants linked
to prognosis that could be evaluated in newly diagnosed
patients. These variants may tell doctors which patients
need aggressive therapy or which treatment works best in
a particular patient.
Rare genes, found faster
Since the original
publication, they
FULL-GENOME COMPARISON
have expanded their
SEQUENCE
METHOD
approach by adding
4 months a DNA barcode onto
each individual's con
tribution to the pooled
DNA sample. This enables them to trace rare variants back
to individual patients, which was not previously possible.
The investigators also are collaborating with other
Washington University researchers by using the method to
find rare variants in other complex diseases: newborns with
lung disease, children witb clubfoot, brain tumors or sickle
cell disease, adults with heart failure and lung disease.
"Ultimately, we think we' ll be able to use this simple
method to find important genetic variations," Mitra says.
"Lots of people have done genetic studies and have come up
empty-handed. They're anxious to get at rare variants, and
we think this method will get us there, not just for cancer
but for many important diseases." 0

2.5 years
$200,000

$6,000
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Even though brain surgeons perform pituitary
surgery, the pituitary gland isn't really part of the
brain. The pea-sized gland nestles in a protective
bone cavity in the center of the head, directly
beneath the brain . That puts it right next to critical
arteries, nerves and brain regions, making pitu
itary surgery a very delicate operation indeed.
By far, the most common reason for pituitary
surgery is to remove benign tumors ca lled pituitary
adenomas, which account for about 15 percent
of brain tumors. If these grow large enough, they
can cause headaches and dizziness or press on the
optic nerves and lead to visio n problems.
The pituitary is a hormonal jack-of-all-trades,
sec reting hormones that help regul ate growth,
blood pressure, reproductive functions, energy
metabolism, fluid balance and body temperature.
Pituitary adenomas can increase or decrease pitu
itary hormone production, lead ing to disorders
like Cushing's sy ndrome , which is characterized
by weight gain, high blood pressure and ot her
health issues, gigantism, en larged thyroid ,
inappropriate milk produc tion and many others.
During pituitary tumor surgery, doctors have
to take care to avoid injur y to the carotid arteries
running on either sid e of the pituitary and to the
membrane covering the brain, which is directly
behind the pituitary. Damaging the healthy
portions of the pituitary during surgery co uld
harm hormone production.
The bone cradling the pituitary sits right at
the back of one of the nasal sinuses. So most of
22 Washington University School of Medicine

the time, surgeons can reach pituitary tumors by
go ing through these sinu ses instead of opening
the sk ull and moving aside brain tissue.
For this kind of pituitary tumor operation,
Chole and Dacey divide tasks. Chole starts the
procedure by cutting through or removing bone
and cartilage struc tures within the nasal sinu ses
to expose the bone covering the pituitary. Then
Dacey goes in to exc ise the tumor.
Until recently, it was routine to get to pituitary
tumors through an und er-th e-lip , or sublabial,
approach. 111at involves pulling up the upper
lip and making incisions under it to get to the
sinus cavities.
Unfortunately, after such operations , patients
might have lip swelling, as well as lingering numb
ne ss of the upper front teeth and lip. Sometimes
patients' dentures don't fit well after the surgery
and have to be remade. Packing the area with
absorbent materials to prevent bleeding and fluid
lea kage often causes face and head pain during the
recovery period.
To alleviate those problems, Chole and Dac ey
started performing the operation by entering the
nasa.! cavity through a nostril an d then going into
the sinus cavities at the back of the na sa l cavity.
At times, neurosurgeons perform this surgery
without a retractor, but many sit uations ca ll for
use of the in st rument. Unfortunately, he found
that available retractors weren't all that practical
for doi ng this procedu re th rough a nostri l.
Winter 2009

The main component of pituitary retractors
is something that looks like a metal tube, about
three to four inches long, split lengthwise; the
halves of this tube are called blades. Attached to
one end of the blades at a right angle are handles
th at allow surgeons to manipulate the instrument
and to spread the two blades apart. The blades
hold tissues out of the way a nd give surgeon s a
clear pathway to in sert implements for cutting
out the tumors.
"We started doing through-the-nose surgery
with existing instruments ," Chole says. "But we
found they didn 't angle correctly and the size
was wrong. We could get by most of the time,
but the view of the pituitary wasn't as good as
we wanted ."
So, in his home workshop, Chole made new
blades for one of the standard retractors. These
new blades had an upswept curvature at the end
and a subtle flaring that made it easier for the
surgeons to reach upward to the pituitary and
push aside adjacent tissue. Chole also made the
blades small enough to fit through a nostri I.
That patched-together instrument was better,
but the s urgeons found a few more ways to
improve the design. Working with instrument
manufacturing company Anspach, Chole and
Dacey have developed a final product, a stainless
steel pituitary retractor with aluminum blades
in three sizes suitable for children and small
and large adults. The company will market
the device.
outlook.wustl.edu

Their completed retractor design is unique in
allowing the blades to move in two ways: opening
in parallel or opening at an acute angle. It also
has a bar that rests on the patient's forehead to
s tabilize the instrument.
The retractor can grip on to an endoscope, a
lighted tube with a wide -angle lens . The endoscope
can be fed through the retractor and back to the
a rea of the tumor. But it also can be moved aside
so it doesn't get in the way of the surgical instru
ments needed to take out the tumor.
"Because the retractor can hold an endoscope,
that fre es a surgeon from having to hold it," Dacey
says. "111e retrac tor also makes it easier to go back
and forth between using an endoscope and using
an operative microscope to see the tum or. It's also
very good that the retractor is adjustable to allow
us to deal with an individual patient's anatomy."
Patients are I ikely to be pleased at the chance
for pituitary surgery with fewer complications
and no external stitches or scarring. Chole says
one patient was surprised when he awoke from
anesthesia after a recent operation.
"He felt so good," Chole says , "that he accused
us of not doing the surgery at all." 0

The completed
device -

in

three sizes
suitable for
children and
small and large
adults -

will

be marketed.
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The Ochieng brothers wanted
nothing more than to be
physicians. Little did they
realize that their dedication
to giving back would bring
them to the attention of the
world with the making of an
extraordinary documentary.

an
PASSION

WO BROTHERS FROM KENYA
say they owe much to their home village of Lwala,
a community that has supported them throughout
their educational careers. In turn, the brothers
wanted to give back to Lwala and, at the same time, honor
their parents, Erastus and Margaret, who had both died
from complications of HIV/AIDS. While studying in the
United States, both Milton, an internal medicine resident at
Barnes-Jewish Hospital and Washington University School
of Medicine, and Fred, a medical student at Vanderbilt
UniverSity, worked tirelessly to raise funds to build a health
clinic in Lwala. The Ochieng Memorial Lwala Community
Health Center opened in 2005; to date, more than 32,000
patients have been treated there. "For us," says Milton, "it's
been realizing that every ounce of our energy - every extra
second we spend answering an e-mail, making a phone call,
or giving a talk somewhere - can translate to a life saved."

St. Louis premiere event
The red carpet was unfurled on November 3 at the Missouri Botanical
Garden to showcase "Sons of Lwala," a moving documentary that
examines the challenges and triumphs of Milton Ochieng, his
brother, Fred, their friends, family and fellow villagers in building
a health clinic in their hometown of Lwala, Kenya. Washington
University School of Medicine,
Barnes-Jewish Hospital and others

learn more and view the trailer at:

Iwalacommunityalliance.org

partnered to host the viewing.
The film , directed by Barry Simmons, chronicles the journey of the
brothers, who left Lwala to attend college and then medical school
in the United States, but never forgot their impoverished village.
The Ochieng Memorial Lwala Community Health Center they
founded is the first medical facility in Lwala, a village that has no
electricity or running water.
Proceeds from the sale of the documentary support the Lwala
Community Alliance in sustaining existing programs and developing
new initiatives, such as a maternity program and medical training .
Overall, the Alliance works to empower the people of Lwala by
providing jobs, training, education and improved health.
Far left: Kenneth S. Polonsky, MD,
Busch Professor and head of the
Department of Internal Medicine,
left, and Melvin S. Blanchard, MD,
associate professor and director of
the department's residency pro
gram. Left: Kenyan ambassador
Peter Ogego, center, with Fred
Ochieng, left, and Milton Ochieng.

The Ochieng brothers
pose with School of
Medicine volunteers
who raised nearly
$20,000 at the movie
premiere for the Lwala
Community Alliance,
agroup that works to
advance the physical
health, educational .~
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scholarships

BY BRIAN DEFILIPPIS

Financial tipping point
Scholarships help future medical professionals train to serve others
or many students, receiving a scholarship to Washington
University School of Medicine represents a tipping
point - that critical moment when a person arrives
at a decision. A scholarship provides an extraordinary
opportunity to train at an acclaimed institution alongside
world-class scientists, physicians and health care profession
als. It also represents faith in individuals and their futures .
Students who enroll at Washington UniverSity School of
Medicine come from diverse ethnic, geographic, economic
and social backgrounds. They arrive on campus with dis
tinct professional goals and career aspirations, while being
bound together by a common desire to heal the patients that
they will serve later in their careers. It is this unique balance
between the dissimilar and similar that enriches the robust
academic environment in which all students train as physi 
cians, research scientists, physical therapists, occupational
therapists and audiologists.
"1 want to practice medicine in underserved and under
developed areas," explains Joseph B. Song, a first-year
medical student. "However, the cost of a medical education

F
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presented a Significant hindrance." Song received a scholar
ship to attend Washington University and plans to pursue
his goal to practice in underserved areas. He is getting a
head start through his involvement in community outreach
efforts offered at the School of Medicine.
Many students at Washington University have simi
lar stories. More than 70 percent of students currently
receive scholarship support during their academic career.
Scholarships, in combination with student loans, enable
many students to attend Washington University School of
Medicine and fulfill their tremendous potentiaL
"Washington University has enjoyed wonderful success
in its ability to recruit many outstanding students to the
School of Medicine and our top-ranked Programs in
Audiology and Communication Sciences, Physical Therapy
and Occupational Therapy," says Larry J. Shapiro , MD,
executive vice chancellor for medical affairs and dean of
Washington University School of Medicine. "Despite our
past success, we must continue to find ways to lessen the
overwhelming financial burden challenging our students."
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Opening Doors to the Future
The Scholarship Initiative for Washington University School ofMedicine
Q: How much student financial aid
was provided in 2009-1 O?

A: More than $15 million. Of this,
scholarship support exceeded $6 million.
Q: What is the average student debt?
A: Medical students graduate with
an average debt exceeding $100,000.
Students in the Programs graduate
with average debts ranging from
$85,000 to $96,000.

Q: Who will receive my scholarship?
A: You may direct your scholarship to
support students in medicine, audiology
and communication sciences, occupa
tional therapy or physical therapy.
Q: What are the giving options?

A: Giving options include an annual
scholarship with a single gift or an
endowed scholarship with a gift that
is invested and provides income in

Opening doors to the future
The need for scholarships is significant and expected to
increase in the years ahead, which is why Washington
University has launched Opening Doors to the Future:
The Scholarship Initiative for Washington University.
This five-year efFort was formally launched on November 7,
2009, in conju nction with Founders Day and is designed to
augment support for student scholarships.
The School of Medicine efFort, led by co-chairs Gordon
W. Philpott, MD 61, and Jay Kaiser, MD 72, has a goal of
$25 million and will be part of the university-wide goal of
$150 million. Through this effort, the School of Medicine
has enlisted the help of alumni who have seen the tangible
benefit of scholarships. As volunteers, they will assist the
School in its efForts to boost scholarship support for students.
"TIle students who come to Washington UniverSity are of
exceptional ability. Scholarship support is often the decisive
factor that enables so many of these talented individuals to
achieve their true potential," observes Philpott.
"Scholarships allow students to pursue careers based
on passion and not financial circumstances," adds Kaiser.
"TIle Scholarship Initiative will ensure that current and
future students have the same opportunities that we had
as students."

Broadening the margin for excellence
The scholarships that are offered by Washington UniverSity
School of Medicine comprise both endowment income and
annual contributions from alumni, friends and organiza 
tions and have enabled the school to recruit the nation's best
students for more than a decade. Many of the other leading
medical schools are quickly clOSing the gap. These institu 
tions possess endowments that surpass that of Washington
University School of Medicine, and they are able to offer
larger scholarships to the most outstanding students.
The Scholarship Initiative will help to maintain and
expand Washington UniverSity'S competitive edge as well
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perpetuity. Giving methods include out
right gifts of cash or securities, mUlti-year
pledges, and planned gifts including
estate and life-income gifts. Donors may
name their annual or endowed scholar
ships to honor themselves, their family, a
friend, a current or former faculty member,
or in memory of a loved one.
For more information, please contact
Pamela Buell at 314-935-9691.

as keep profeSSional education affordable for a greater
percentage of students.
Annual scholarships will offer opportunities to students
currently enrolled at the School of Medicine, wbile endowed
scholarships provide support for students who will study
here now and in future years. Regardless of the type of
scholarship a donor chooses, the students will benefit.

The cost of excellence
During the 2009-10 academic year, the School of Medicine
awarded more than $15 million in financial aid to its
students, including tbose enrolled in the Programs in
Audiology and Communication Sciences, Physical Therapy
and Occupational Therapy. Of this total, scholarship support
exceeded $6 million.
And yet, the burden of debt remains daunting for many
of our students.
ApprOXimately three quarters of medical students grad
uate with debt, and more tha n half of these students leave
with debt exceeding $100,000. Similarly, the average debt
of students graduating from the Programs in Audiology
and Communication Sciences, PhYSical Therapy and
Occupational Therapy exceeds $85,000 - a burden made
more severe by an average profeSSional salary of $50,000.
Second -year medical student Lucy Zhang was at a
tipping pOint. Faced with a choice of schools that were
affordable but not a great fit and schools that were desirable
but unaffordable, scholarships made the difference. "Having
to take on less debt during my medical education eliminates
many stresses and affords me the opportunity to explore
various fields of medicine," Zhang says.
Similarly, Washington University School of Medicine
stands at a tipping point. TIle Scholarship Initiative can
provide necessary resources that will enable the School of
Medicine to sustain its momentum well into the future. "We
have incredible students at Washington UniverSity School
of Medicine who graduate with a Significant debt load," says
Shapiro, "and we are compelled to alleviate this burden."
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grateful patient

BY GWEN ERICSON

Linda and Harvey Saligman

Taking research to the next level
H
rvey Saligman, a St. Louis
area priva te investor, was in
New York for a business t ri p
when suddenly his hip began hurting.
The pain was severe and persistent.
"I was having great difficulty walking,"
Saligman says. "I had always prided
myself that I could walk to almost
anything, but I had to hire a car to get
around beca use my leg hurt so badly."
Back home in St. Louis, Saligman
was diagnosed with multiple myeloma ,
a type of blood cancer that originates
in the bone marrow. He came to the
School of Medicine for care under
myeloma speciali st Ravi Vij, MD,
associate professor of medici ne in the
Division of Oncology.
Today, Saligman is in remission ,
but the experience inspired a new ven
ture . He and his wife, Linda , talked
about how they could make a differ
ence to others faci ng myeloma.
"Having been associated with the
university for more th a n 20 years,
I know it has great physic ians and
researchers," Saligman says. He has
served as a member of the Washington
University Board of Trustees since
1986 and has been on the Washington
University School of Medicine
National Co uncil since the mid-1990s.
"Lind a and I saw that other places
were better known for myeloma
research , but we thought, why not
here?" he says. "So with the goal of
moving the university to the fore 
front in myeloma research, we set up
a fund, and we hope it will attract
additional support."
The Harvey and Linda Saligman
Multiple Myeloma Research Fund will
support basic an d clinical research in
the Div is ion of Oncology to under
stand the causes of myeloma and to
develop improved treatments and
ultimately a cure for the disease.
28 Washington University School of Medicine

"We are at a critical point and ready
to go from a local and regional center
to a national myeloma center," says
divi sion director John F. DiPersio, MD,
PhD, the Lewis T. and Ro sa lind B.
Apple Chair in Oncology. "We have a
nationally and internation ally recog
nized clinical program now fu r ther
strengthened by strong bas ic science
focused on the biology and genomics
of myeloma. But to go to the next level,
we need community philanthropic
support ; that will make the difference."
The division conducts a number
of clinical studies to evaluate new
myeloma treatments, many of which
Vij head s. Washington University is
a member of the Multiple Myeloma
Research Consortium, an organ ization
of 13 lead ing U.S. academic centers
designed to speed development of
new myeloma therapies. As a mem
ber, the medical school can prov ide
patients access to new medications that
wouldn 't otherwise be available.
"Mu ltiple myeloma is rapidly
undergOing a therapeutic revolution,"

Vij says. "We have already made great
strides in improving the life expec
tancy of myeloma patients and hope
that we can someday come up with
curative therapies."
At the basic-science level , three
key resea rch areas contribute to the
invest igation of myeloma at the School
of Medicine. Researchers tap into the
rise of genome science and the pres
ence of the Genome Center to identify
the genetic abnormalities th at initiate
the disease and contribute to its pro
gression. They also study the effect of
novel compounds in la boratory models
of myeloma and conduct re search in
basic bone biology to find out how to
prevent bone damage from myeloma.
Other projects look into myeloma
incidence an d distribution to isolate
the disease's risk factors.
Ultimately, generosity such as
the Saligmans' will move this critical
research forward, helping Washington
University School of Medicine to
quickly develop a leading program
for multiple myeloma research .

John F. DiPersio, MD, PhD, left,

Harvey Saligman and Ravi Vij, MD
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APRIL 29 - MAY 1

REnew
friendships

REthink
medicine
with CME
opportunities

REconnect
at the fun
Family Picnic

REdiscover
St. Louis

eunion 2010 is right around the corner, with an exciting new schedule of events!
You will have an opportunity to take CME courses offered by fellow alumni and
current faculty members. There will be trips to the St. Louis Zoo, the Science Center
and the Missouri Botanical Garden. You can enjoy ajog through Forest Park and take
in aCards game! And of course, you will have the opportunity to reconnect with
classmates at the Friday night class parties and the Saturday night Alumni Banquet.

R

Look for registration materials in January 2010,
or talk to a member of your Reunion Class Committee.

REvisit the
ever -changing
medical campus

The School of Medicine is aided in its Reunion planning by many loyal alumni. We are grateful
to the following individuals who have volunteered to make the 2070 event a special weekend.

Robert Drews, MD 55
John Martin, MD 55
E. Robert Schultz, MD 55
Nathan Simon, MD 55
W. Yates Trotter, MD55
Miles Whitener, MD 55
Floyd Bloom, MD60
Paula Clayton, MD 60
Robert Edmonds, MD 60
David Rosenbaum, MD 60
Gustav Schonfeld, MD 60
Eli Shuter, MD 60
Gabriel Zatlin, MD 60
James Louie, MD 65
James Marks, MD 65
~

F. Thomas Ott, MD 65
Margaret Telfer, MD 65
Donald Anderson, MD 70
William Blair, MD 70
William Blattner, MD 70
Joann Data, MD 70
Marilyn Escobedo, MD 70
Francisco Garriga, MD 70
Scot Hickman, MD 70
Paul Mennes, MD 70
David Ortbals, MD 70
William Shearer, MD 70
David Clifford, MD75
Jo-Ellyn Ryall, MD 75
Robert Cooper, MD 80

James Fleshman, MD 80
Thomas Loeb, MD 80
Bert Mandelbaum, MD 80
William Morgan, MD 80
David Mutch, MD 80
Herluf Lund Jr., MD 85
Paul Miller, MD 90
Linda Peterson, MD 90
Martha Terry, MD 95
Po Wei Wang, MD 95
Michael Kappelman, MD 00
Michael Peelie, MD 00
Clare Pipkin, MD 00
Geoffrey Uy, MD 00
Erik Wallace, MD 00

For more details on MD Reunion 2010, visit: medicalalumnLwustl.edu ~

classnotes
1940s
Morris Alex, MD 43
Alex is retired and resides in St. Louis MO.
He enjoys writing and consulting
for ALU Social Security. He is most proud
of his children, grandchildren and great
grandchildren.
Sarah Arpe Malin, MD 48
Malin, who is retired from pediatrics, is
an active member of hospice. Her late
husband was Jacob Malin, MD 48. She
is a member of the North Lake Tahoe
Historical Society, as well as the American
Association of University Women. She
enjoys studying French and exercising
daily. Malin resides in Kings Beach CA.

1950s
Lowell A. Gess, MD 51
Gess retired as a misSionary with United
Methodist Committee of Relief (UMCOR)
as a member of the General Board of
Global Ministries in 1975. He first traveled
to Africa as an eye surgeon in 1953 with
his wife, Ruth, a registered nurse, and their
four children. He has remained involved
with three eye hospitals in Sierra Leone,
Nigeria and Zimbabwe for many years and

is thrilled that all of them are doing well
with excellent staff. He had the opportu
nity to visit the Kissy United Methodist
Eye Hospital in Sierra Leone in April and
May of 2009, where it was rewarding to
see the highly trained ophthalmologist
at Kissy providing the best eye care in
the least developed country of the world.
Gess currently resides in Alexandria MN.
William Shieber, MD 53
Shieber has retired from surgery and lives
in St. Louis MO with his wife, Horty. He
plays golf in his spare time and enjoys
being a docent at the Saint Louis Zoo.

1960s
Robert Hunt, MD 63
Hunt is retired. As he reflects on his surgi
cal career, he is most proud of his devel
opment of a breast care diagnostic and
treatment center. In his spare time, he likes
to travel, play golf and read. He resides in
Cape Girardeau MO with his wife, Sue.
Edgar C. Boedeker, MD 68
Boedeker left the University of Maryland
and moved to Placitas NM where he is a
professor of medicine at the University
of New Mexico. He enjoys sailing when
he visits Maryland. He is a member of the
American Society for Microbiology.

1970s
Bela S. Denes, MD 73
After practicing urology for 23 years,
Denes joined the pharmaceutical industry.
Currently head of urology drug develop
ment for Spectrum Pharmaceuticals in
Irvine CA, he also has provided urology
services at clinics for the indigent in
Orange County. He resides in Laguna
Beach CA.
Robert Schmitz, MD 78
In 1985, Schmitz left medicine to pursue
a career in real estate. He is married to
Amy Csorba, MD, who practices family
medicine. They have three children and
reside in Durham NC.

1980s
Mark Boothby, MD 83
Boothby is a professor in the Department
of Microbiology and Immunology at
Vanderbilt University School of Medicine.
In recent years, he has published many
research articles. He also has stayed
funded, taught students, and had lots
of great times with his family. He resides
in Nashville TN with his wife, Jin Chen,
and their son .

2nd Century Awards
The 2009 2nd Century Awards were
presented at a dinner held at the Ritz
Carlton Hotel in Clayton MO on October 3.
The awards, bestowed annually since 1991,
mark Washington University School of
Medicine's entry into its second century
of leadership in patient care, teaching
and research. The 2nd Century Award
recognizes individuals whose long-term
commitment and participation truly have
made a difference, enabling the School
of Medicine to look to the future with
strength and confidence.

2nd Century Award recipients: Gerald Medoff, MD 62,Ieft, Doris Schnuck and Carl Frieden, PhD.
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Janie Cox, MD 83
Cox recently retired so that she can spend
more time with her children and volunteer
in their schools. She loves her time with
her family; they often go hiking and
camping. Cox resides in Portland OR.
Eric Stevens, MD 86
Stevens is a member of a 12-person
pulmonary, critical care and sleep medi
cine group in loveland and Fort Collins CO.
He is married and has two girls, ages 14
and 10. He enjoys cycling, rowing and
playing bass guitar.

1990s
Peter M. Bridge, MD 93
Bridge is a private practice plastic surgeon .
He spends his free time reading, traveling
and swimming. He resides in Temple
Terrace FL with his wife, Donna, and his
two sons, Holden and Blake.
Lynne Champagne, MD 93
Champagne has a private practice in
internal medicine. She works a reduced
schedule in order to spend time with her
young children. She lives in San Diego CA
with her husband, Wilfred Kearse.
Pablo Adler, MD 98
Adler is the director of education for the
Department of Anesthesia at Christian
Care Health System. He resides in
Wilmington DE with his wife, Christina.
He enjoys lifting weights, martial arts,
traveling and seeing his kids grow.

2000s
Cynthia Chiu, OT 04
Chiu recently returned to St. Louis from
Kansas City KS to be closer to family.
She has two small children: Lucas, 2, and
Peter, 1. She resides in Kirkwood MO.
Beth Schukman Daze, PT 06
Daze, who works at an outpatient physical
therapy clinic in Raytown MO, recently was
promoted to clinic manager. She enjoys
her new position and looks forward to
many years within the same company. She
was married on May 9, 2009, and bought a
house in Kansas City KS this past summer.
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IN

MEMORY

Marjorie S. Dunlap, NU 42
Dunlap died in Santa Rosa CA on July 20,
2009, at age 91. She was a professor and
dean of nursing at the University of Hawaii
and at the University of California-San
Francisco, from which she retired in 1982.
Elmer LeVerl Barrett, MD 43
Barrett died at home on Aug. 27, 2009,
at the age of 93 . He liked to note that he
practiced internal medicine in an era when
doctors took phone calls and made house
calls; his medical training also coincided
with the introduction of antibiotics when,
as he said, "people who used to die lived:'
Phillip Comens, MD 51
Comens died on January 9, 2009, at his
home in Sunset Hills MO. He was 85.
An assistant professor of medicine at
Washington University School of Medicine,
he carried out extensive research in hyper
tension and cardiology before going into
private practice. He also was a flight sur
geon with the Missouri National Guard.
Clifton Brooks Sr., HS 52
Brooks died on May 8, 2009, in Norman
OK at the Oklahoma Veterans Center. After
graduating from Washington University
School of Medicine, he attended UCLA,
completing a masters degree in public
health. His military service spanned
34 years and three branches of the mili
tary. He enjoyed his life and family, was an
Eagle Scout and a Past Master of lexington
lodge #72, and spent many hours
researching family genealogy.
Rhys A. Williams, MD 53
Williams died on April 19, 2009, in
San Antonio TX. He practiced general
surgery for 32 years at the North Arkansas
Medical Center, from which he retired in
1991 . He and his wife, Bina, then moved to
Aspen CO. He was a medical expert for the
Social Security Administration until shortly
before his death.
John G. Durham, DE 56
Durham died on Aug. 20, 2009, after a
nine-year struggle with cancer. He was 78.
An assistant professor of clinical dentistry
at Washington University, he ran a private
general dentistry practice for 50 years.

Marshal Glyn Maggard, HA 60
Maggard died on March 17, 2009. He
worked as an assistant administrator at
Hillcrest Medical Center in Tulsa OK, then
later as CEO of Galesburg Cottage Hospital
in Galesburg Il, until he retired in 1983.

FACULTY
M. Kenton King, MD
King, dean of Washington University
School of Medicine for nearly 25 years,
died on Oct. 15, 2009, at his home in
University City MO. He was 84. He was
one of the longest-serving medical deans
in the United States, as well as one of the
most successful. Under his guidance, the
School of Medicine became one of the
foremost institutions of medical educa
tion in the world. Through his leadership
and vision, in particular his instrumental
role in recruiting new heads of all medical
school departments, he shaped the course
of the institution. He also championed a
dramatic change in the composition of the
student body, recruiting more minority
and women students. During his tenure,
the school's campus grew tremendously,
and he worked to strengthen the amount
and quality of research and to bolster
alumni relations. He is survived by his wife,
June Greenfield King, a 1951 graduate
of the Washington University School of
Nursing, four sons and eight grandchil
dren. He was preceded in death by a fifth
son, Washington University alumnus and
University City Police Sergeant Michael
King, who was killed while on duty in 2008.
Lee N. Robins, PhD
Robins, professor emeritus of social science
in psychiatry at Washington University
School of Medicine, died peacefully at
home on Sept. 25, 2009, following a long
battle against cancer. She was 87. A world
leader in psychiatric epidemiology research,
she had worked in the Department of
Psychiatry for more than 50 years. She is
survived by husband Hugh Chaplin Jr., MD,
an emeritus professor in the Departments
of Medicine and Pathology and the former
head of the Irene Walter Johnson Institute
of Rehabilitation, four sons, eight grand
children and two great-grandchildren.
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DON AND MARY HARKNESS,
both MD 58, have established
an endowed scholarship fund

Your School of Medicine

in memory of their daughter,
Laurel, with current gifts and
abequest in their estate plan.

Include a bequest in your estate.

Laurel Harkness, MD 86,
died in 2003.

Consider providing a bequest that will support future
programs or endow a professorship, scholarship or
research fund in your name or that of a family member.

Call (314) 935-5373 or (800) 835-3503
For more information, complete the reply card
or e-mail us at plannedgiving@wustl,edu.
Visit our web site: plannedgiving.wustl,edu

Seek advice from your tax or legal adviser when (onsidering a bequest.
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Washington University School of Medicine and You:

Philanthropic Partners
I,earn n10

lbout vour 0

to

here are many ways you can make
a gift to Washi ngton University
School of Medicine. Your giving
supports endeavors that benefit human
health, and we can help you match your
personal philanthropic goals with
academic priorities.

OPPORTUNITIES

I am interested in supporting Washington University
School of Medicine. Please send information about:

o

o

GIFT ATTRIBUTION

o

I wis h to make a Memorial gift.

o

I wish to make an Anonymous gift.

Unrestricted Fund for the School of Medicine
This gift will be used to su pport priorities at the

GIVING OPTIONS

School of Medicine.

o

Gift Annuity

Scholarships: Opening Doors to the Future

Please provide information about gift annuities to

The sch olarsh ip initiative t ha t hel ps today's students

benefi t Washington Un iversi ty Sch ool of Medicine.

become to morrow 's medical professionals.

o

lnedi,:in

If you wish to make a gift or request more
information, please complete and return
this card. Or call the Office of Medical
Alumni and Development at (314) 935-9691
for a personal consultation. Thank you for
your interest and ongoing support of the
School's vital mission.

T

GIVING

tran~tonn

BioMed 21
BioMed 21 is a cu tting-edge, multidisciplinary effort
to rapidly tra nsl ate the discoveries of basic science

o

Estate Plan

o

Cash

o

Securities

o

Real Estate

into cl inica l care.

o

Specific Department/Division

CONTACT INFORMATION

o

Name_________________________________

Specific Program

Add ress,________________________________

o

Specific Physician/Researcher/Professor

City__________________________
State

o

Other

Zip _____________

Daytime Phone_ _ _ __ ________________
E-mail_ _ _ _ ______________________
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